Results 61 to 70 of about 12,171 (216)
Antithyroid Drug-Induced Aplastic Anemia
Thyroid, 2008 Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life threatening side effects such as agranulocytosis and aplastic anemia (AA). We review all cases of antithyroid drug induced AA and describe, as illustrative cases, two women with Graves' disease ...
Thomas, D. +5 more
openaire +3 more sources
Eye &ENT Research, Volume 3, Issue 1, Page 5-10, March 2026.ABSTRACT Background Thyroid‐associated ophthalmopathy (TAO) may lead to severe exophthalmos and dysthyroid optic neuropathy (DON), which can threaten visual function. Orbital decompression surgery is often required when medical therapy is insufficient; however, traditional deep lateral wall decompression techniques remain associated with several ...
Shuo Wu +4 more
wiley +1 more source
Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis [PDF]
, 2003 A 36-year-old Chinese man presented to the Queen Mary Hospital in August 1999 with a 2-week history of jaundice due to propylthiouracil treatment for thyrotoxicosis. He had previously received carbimazole but had developed an urticarial skin rash after 2
Chan, AOO +4 more
core
Food Science &Nutrition, Volume 14, Issue 3, March 2026.Curcumin supplementation resulted in a reduction in IL‐6. Additionally, it decreased hs‐CRP levels in patients with HT, with a mean reduction of whereas the placebo group exhibited an increase of +1.53 ± 3.33 mg/L (p = 0.305). Also, curcumin supplementation significantly reduced NF‐κB levels in patients with HT, while the placebo group showed a slight ...
Fatemeh Bourbour +6 more
wiley +1 more source
ChemistryEurope, Volume 4, Issue 2, February 2026.The cis‐2,3‐bis(trifluoromethyl)cyclopropyl chemotype is introduced. The steric demand of this motif is intermediate between that of the heptafluoroisopropyl and prefluorotertbutyl groups; yet, it induces significantly less lipophilicity than these due to its facial polarity.
Daniel Gaviña +5 more
wiley +1 more source
Current and emerging treatment options for Graves’ hyperthyroidism
Therapeutics and Clinical Risk Management, 2009 Prakash Abraham1, Shamasunder Acharya21Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, UK; 2Department of Endocrinology, John Hunter Hospital, New Lambton NSW, AustraliaAbstract: Radioiodine, antithyroid drugs and surgery have been well ...
Prakash Abraham, Shamasunder Acharya
doaj
Thyroid disease : diagnosis and management of Hyperthyroidism [PDF]
, 2005 This short review article aims to provide updated information on the diagnosis and management of hyperthymidism.
Caruana, Noel
core
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 2, February 2026.ABSTRACT Purpose Confounding is a key concern in observational studies using healthcare databases. The high‐dimensional propensity score (HDPS) algorithm is an approach for generating and prioritising proxy variables, leveraging all available information in a database to mitigate residual confounding.
Edmund C. L. Cheung +4 more
wiley +1 more source
The evolving therapeutic landscape of Graves’ disease in adults: present and future
European Thyroid JournalThe therapeutic landscape of Graves’ hyperthyroidism has been rapidly evolving in the past few years. There has been a shift worldwide toward antithyroid drugs as the preferred first-line therapy with significant interest in thyroid function preservation,
Marius N Stan, Chrysoula Dosiou
doaj +1 more source
Long-term outcomes of graves disease in children treated with anti-thyroid drugs
Pediatrics and Neonatology, 2020 Background: Graves disease (GD) is the most common cause of thyrotoxicosis in children and adolescents, accounting for 15% of all thyroid diseases during childhood.
Ya-Ting Chiang +11 more
doaj +1 more source